High Tech Pharm Co. Ltd (106190) — Cash Flow Reinvestment Rate
High Tech Pharm Co. Ltd (106190) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting ₩673.84 Million (capex ₩516.00 Million plus investments ₩-157.84 Million) from operating cash flow of ₩6.60 Billion. See High Tech Pharm Co. Ltd (106190) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
High Tech Pharm Co. Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for High Tech Pharm Co. Ltd across 9 annual periods. For the full cash flow conversion analysis, see 106190 cash flow conversion.
Annual Cash Flow Reinvestment Rate for High Tech Pharm Co. Ltd (2014–2024)
Year-by-year capital reinvestment analysis for High Tech Pharm Co. Ltd. See 106190 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.22x | ₩3.28 Billion | ₩14.69 Billion | ₩2.13 Billion | ▼ -94.5% |
| 2023 | 4.07x | ₩11.85 Billion | ₩2.91 Billion | ₩5.09 Billion | ▲ +1842.2% |
| 2021 | 0.21x | ₩1.45 Billion | ₩6.93 Billion | ₩859.60 Million | ▼ -91.8% |
| 2019 | 2.56x | ₩6.36 Billion | ₩2.48 Billion | ₩2.16 Billion | ▲ +33.4% |
| 2018 | 1.92x | ₩10.33 Billion | ₩5.38 Billion | ₩8.96 Billion | ▼ -7.9% |
| 2017 | 2.08x | ₩11.36 Billion | ₩5.45 Billion | ₩11.27 Billion | ▼ -90.9% |
| 2016 | 22.78x | ₩32.99 Billion | ₩1.45 Billion | ₩23.35 Billion | ▲ +797.2% |
| 2015 | 2.54x | ₩32.27 Billion | ₩12.71 Billion | ₩19.52 Billion | ▲ +164.6% |
| 2014 | 0.96x | ₩9.76 Billion | ₩10.17 Billion | ₩9.38 Billion | — |